J Diabetes Investig. 2021 Jun 4. doi: 10.1111/jdi.13607. Online ahead of print.
ABSTRACT
AIMS/INTRODUCTION: This 6-month, single-center, prospective, open-labeled, randomized trial was designed to investigate whether physician’s diabetes self-management education (DSME) using an education tool developed by the Japan Association of Diabetes Education and Care (JADEC) and a self-monitoring of blood glucose (SMBG) analyzer improves glycemic control in individuals with type 2 diabetes receiving insulin and SMBG.
MATERIALS AND METHODS: Participants were randomized into intervention (I) and control (C) groups. Both groups received physician’s DSME at each hospital visit, while the JADEC education tool and the SMBG readings analyzer was used in Group I but not Group C. All participants filled out a diabetes treatment-related QOL (DTR-QOL) form and an original questionnaire on SMBG use with 5 questions (Q1-Q5) before and after the study period.
RESULTS: A total of 76 individuals were recruited and randomized. HbA1c was significantly improved during the study period in Group I, while no significant change was observed in Group C. Change in HbA1c was greater in Group I although it did not reach statistical significance. The DTR-QOL total score was not changed in either group. Interestingly, the score of Q1 (“How important is SMBG to you?”) in the SMBG questionnaire was unchanged in Group I, while it was significantly decreased in Group C. HbA1c change was independently associated with changes in insulin dose and SMBG Q1 score.
CONCLUSION: Greater HbA1c-lowering by physician’s DMSE using the JADEC education tool and SMBG analyzer in individuals with type 2 diabetes receiving insulin and SMBG was suggested but not confirmed.
PMID:34087060 | DOI:10.1111/jdi.13607
